Affiliations

Adherex Technologies

Adherex Technologies Ottawa, Ontario, Canada
Ascenta Therapeutics

Ascenta Therapeutics Malvern, Pennsylvania, United States
Jiangsu Ascentage Biomed Development

Jiangsu Ascentage Biomed Development Taizhou, Jiangsu, China
OncoFusion Therapeutics

OncoFusion Therapeutics Ann Arbor, Michigan, United States
Sanofi-Aventis

Sanofi-Aventis Paris, France
United States Department of Health and Human Services (HHS)

United States Department of Health and Human Services (HHS) Washington, District of Columbia, United States
University of Michigan

University of Michigan Ann Arbor, Michigan, United States
Portfolio Summary
250 documents
  • Research Grants 6 view all grants

    $348.2K
    2000

    $465.4K
    2001

    $229.5K
    2003

    $546.8K
    2004

    $561K
    2005
  • Publications 163 view all publications
    • 13
      Tumor Suppressor Protein p53/metabolism
    • 12
      Antineoplastic Agents/pharmacology
    • 12
      Apoptosis/drug effects
    • 11
      Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors
    • 9
      Antineoplastic Agents/chemical synthesis
    • 9
      Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors
    • 8
      Drug Design
    • 8
      Proteins/chemistry
    • 7
      Apoptosis
    • 7
      Inhibitor of Apoptosis Proteins/antagonists & inhibitors
    • 18
      C07D - Heterocyclic compounds
    • 16
      A61K - Preparations for medical, dental, or toilet purposes
    • 4
      G01N - Investigating or analysing materials by determining their chemical or physical properties
    • 2
      C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
    • 1
      Y02T - Climate change mitigation technologies related to transportation